To be part of our organization, every employee should understand and share in the YNHHS Vision, support our Mission, and live our Values. These values—integrity, patient-centered, respect, accountability, and compassion—must guide what we do, as individuals and professionals, every day.
The Molecular Diagnostic Laboratory is a CLIA certified laboratory that specializes in the development and performance of clinical molecular diagnostic assays primarily in Hematology/Oncology. Under the supervision of the Laboratory Director, Manager, and Section Coordinator, the Molecular Assay Development Technologist is responsible for performing a wide variety of routine and complex molecular testing to ensure quality patient care. Additional responsibilities include optimization of current laboratory tests and development of new laboratory tests following CAP and CLIA guidelines. Responsibilities will be split, approximately 60% clinical testing and 40% assay development.
Bachelor of Science in Medical Technology, Molecular Biology or equivalent with MT(ASCP) certification, MB(ASCP) certification or equivalent. MB(ASCP) certification preferred. Continuing education in a related discipline desirable.
A minimum of 2 to 3 years clinical laboratory experience in a Molecular Diagnostics laboratory performing a wide variety of tests. At least one (1) year of experience in molecular assay development and validation is desirable.
MT(ASCP) certification, MB(ASCP) certification or equivalent. MB(ASCP) certification preferred.
Strong knowledge of molecular principles and the ability to develop and validate clinical molecular assays according to CAP and CLIA guidelines.
STRONG KNOWLEDGE OF MOLECULAR PRINCIPLES AND THE ABILITY TO DEVELOP AND VALIDATE CLINICAL MOLECULAR ASSAYS ACCORDING TO CAP AND CLIA GUIDELINES.